Colonization factor antigen (CFA) (CFA)

Colonization factor antigens (CFAs) are specialized surface proteins, primarily fimbriae or pili, that enable Enterotoxigenic Escherichia coli (ETEC) to adhere to the human intestinal mucosa (Svennerholm, 2011, Indian J Med Res). This adherence is the critical initial step in ETEC pathogenesis, allowing the bacteria to colonize the small intestine and deliver enterotoxins that cause watery diarrhea (Fleckenstein et al., 2010, Microbes Infect). Over 20 different CFAs have been identified, categorized into various families based on their structural and genetic properties, with CFA/I, CFA/II, and CFA/IV being the most clinically significant (WHO, 2023). As these antigens are essential for infection, they serve as the primary targets for vaccine development, including whole-cell inactivated vaccines and subunit vaccines designed to elicit protective secretory IgA responses (Qadri et al., 2005, Clin Microbiol Rev). Therapeutic strategies also explore the use of monoclonal antibodies to block these antigens and prevent bacterial attachment (Fleckenstein et al., 2010, Microbes Infect). Because adhesion is a prerequisite for disease, targeting CFAs provides a way to intercept the infection before toxin-mediated damage occurs.

Other names

Colonization factorsCFsSurface colonization antigensBacterial fimbriaeBacterial piliCFA/ICFA/IICFA/IVCS1CS2CS3CS4CS5CS6

Induction of mucosal secretory IgA antibodies that bind to colonization factor antigens, sterically hindering bacterial attachment to intestinal epithelial receptors and preventing colonization.